Vaxart Inc. – Filings and Transcripts

OTC: VXRT
Share price (2/27/26): $0.80
Market cap (2/27/26): $191 million

Warning: Large portions of this site require JavaScript enabled in order to function properly. Please make sure JavaScript is enabled in your browser.

Please let us know at support@bamsec.com if you have any questions or concerns.

Search in Documents

Key Exhibits

External Links

Financials Filter

ended 09/30/25 Q3

ended 06/30/25 Q2

ended 03/31/25 Q1

ended 12/31/24 FY 2024

ended 09/30/24 Q3

Prospectuses and Registrations Filter

Removal from listing

Prospectus supplement for primary offering

Prospectus supplement for primary offering

Prospectus supplement for primary offering

Registration of securities for employees

Ownership Filter

Cummings James F.

Finney Michael J.

News Filter

Termination of Material Definitive Agreement

Provides Business Update and Reports Third Quarter 2025 Financial Results

Dynavax Enters Exclusive License Agreement for Vaxart’s Novel Oral COVID-19 Vaccine Program

Material Disclosure

Notice of Delisting, Failure to Satisfy Listing Rule, or Transfer of Listing

Proxies Filter

Letter to shareholders

Letter to shareholders

Additional info about upcoming vote

Letter to shareholders

Additional info about upcoming vote

Other Filter

Scanned paper annual report submission

Scanned paper annual report submission

Notice of effectiveness

Correspondence with the SEC

Letter from the SEC